SynBioBeta Speaker

Liliana Nordbakk

NEVA SGR

Partner

Liliana Nordbakk is a Partner at NEVA SGR, the venture capital arm of the Intesa Sanpaolo Group, headquartered in Italy. She leads the firm’s life sciences investment division and is based in San Francisco, bringing a global perspective to early-stage biotech investing. Her focus areas include next-generation therapies, synthetic biology, precision medicine, and AI-enabled drug development.

Liliana’s career spans the intersection of information technology and biotechnology. She co-founded NorCom, a software company that she led through a successful IPO, and later co-founded Kamau Therapeutics, a clinical-stage gene correction company.

A long-standing member of the Silicon Valley investor community, she has been an active angel investor for over a decade and previously chaired the life sciences group at Band of Angels.

At NEVA, she champions transformative technologies that address the root causes of chronic diseases and aging-related decline. She has a particular interest in techbio platforms and frequently bridges European and American ecosystems to support globally scalable ventures.

SynBioBeta 2026 Tickets are Live

Confirmed Speakers

Sessions Featuring

Liliana

This Year

TBD

Session lineup still growing

Purchase Pass

Featuring

Speaker Coming Soon

Fireside Chat

12:00 AM

-

8:30 AM

Human Health

From Cells to Patients: Solving the Scale Mismatch in Virtual Biology

Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?

Purchase Pass

Featuring

Speaker Coming Soon

Previous Speakers Include